Boston Scientific’s TriVascular Stake Gives AAA Market New Entrant

Boston Scientific's investment in abdominal aortic aneurysm device developer TriVascular, Inc., with an option to buy, shows the company is following through on its promise to become a significant player in the potentially lucrative AAA market